Overseas companies face significant challenges and barriers when they come to enter the Chinese market. Unfamiliar with the market status, complex politics and regulations, bare access to on-target partnering opportunities, language, and cultural differences, all of them limit the foreign company’s expansion to this world’s fastest-growing healthcare market. MyBioGate is prepared to provide preliminary consulting with the companies in all stages. From product & technology potentiality analysis to market trends, we will give you comprehensive advice on your plan to enter China.
Our China Focus forums, Global Healthcare Innovation Competitions, and roadshows provide innovative companies who intend to enter China market with platforms for exposure to potential investors and partners. Through speeches, self-scheduled 1-on-1 meetings, and pitches, we ensure you the utmost opportunities to connect with your preferred investors.
MyBioGate professional financial advisory team will guide you to the capital market in China through the original “CDD service model” (Consulting service, Deal Sourcing, Deal Making). We are a trusted partner for companies seeking solutions on China market entry, in/out-licensing, joint venture, and M&A.
Landing in China
MyBioGate leverages global resources to provide you a fully integrated expansion solution to establishing an entity in China. The comprehensive service covers your business plan and development through the lifecycle, including fundraising, consulting, talent recruitment, clinical trials, registration, and branding. We are offering not only the approach to begin your business in China but also to drive your sustainable growth in a new market.